Mr. Eric Cornut served as Chief Ethics, Compliance and Policy Officer of Novartis AG. Mr. Cornut has over 25 years of pharmaceutical management experience. He spent over 20 years at Novartis AG where he led the Integrity & Compliance and the Public Affairs functions. He served as Interim Director General of The European Federation of Pharmaceutical Industries and Associations (EFPIA) until April. He served as Chief Commercial Officer of Novartis Pharmaceuticals, where he was responsible for Global Product Strategy and Commercialization including Medical Affairs, Pricing and Market Access, Health Economics and Outcomes Research as well as Business Development & Licensing. He led Pharma Region Europe for six years where he oversaw the operations of 35 countries with approximately 9,000 associates from 2007 to 2012. He served as Chairman of Novartis Group Japan. He has been a Non-Executive Director of Helsinn Healthcare S.A. since May 18, 2017. He serves as a Member of the Supervisory Board at Stada AG. Mr. Cornut has a Doctoral degree in Law from the University of Basel, Switzerland and a Master of Law degree from the University of California, Berkeley in the United States.

 Business